Clifford Chance houses a ‘dedicated, attentive and competent‘ team, which is known for handling the full spectrum of intellectual property matters, including supplementary protection certificate (SPC) applications and appeals. The group also advises on a broad range of non-contentious issues, including reorganisation projects, and regulatory mandates concerning the advertising of medicinal products. The Barcelona-based practice is jointly led by: Miquel Montañá, a dispute resolution specialist who frequently acts for global pharma clients in patent infringement actions involving generics; Josep Montefusco, who is particularly adept in preliminary injunction applications; Guillermo Guardia, who regularly advises on acquisition and corporate financing transactions, with an emphasis on cross-border M&A; and Carme Briera, who focuses on administrative and public law-related matters. Adrián Crespo is noted for his deep knowledge of IP and unfair competition litigation, particularly in relation to pharma and biotech patents.

Praised for its ‘specialist‘ knowledge of the pharma industry, Faus Moliner‘s Barcelona-based team acts for a diverse client base of major pharma companies and biotech startups. The team handles a broad range of sector specific issues, including product liability claims involving defective medical devices, in addition to appearing before the Spanish Transparency Council. Practice co-head Jordi Faus is noted for his longstanding expertise in handling compliance projects, commercial agreements, and pharma policy matters. Co-head Xavier Moliner is particularly skilled in disputes involving product liability and public procurement. Lluís Alcover‘s primary areas of expertise include market access, and pricing and reimbursement issues.

The team at Fieldfisher is known for exhibiting broad expertise across the entire spectrum of life sciences and healthcare matters, including data protection, competition-related issues, and compliance programmes. Practice head Héctor Jausàs has longstanding experience in pricing and reimbursement issues, advertising matters, and product liability cases. Regulatory expert Gemma Colomer, who regularly assists clients with the implementation of their internal codes of conducts, is well versed in market access mandates relating to medical devices and medicinal products. Gerard Ramo left the team to join the European Medicines Agency in May 2023.

The ‘highly specialised‘ team at Uría Menéndez maintains its stellar reputation for handling the full gamut of issues within the healthcare and life sciences spaces. In addition to assisting clients with their internal public procurement policies, the group advises investors on their public-private relationships, and regulatory issues surrounding the promotion of medicines. Teresa Paz-Ares and Montiano Monteagudo co-lead the team from Madrid and Barcelona respectively. Paz-Ares has extensive expertise in corporate and M&A transactions in the life sciences sector, while Monteagudo acts for numerous global pharma laboratories in disputes involving copyright and patents. Beatriz Cocina in Madrid regularly advises medtech, healthcare, and biotech clients on a broad range of mandates, including pricing and market access, promotional disputes, and financing. Working out of the Barcelona office, Francisco Javier García is noted for his deep knowledge of IP issues, with particular emphasis on privacy, unfair competition litigation and drug advertising.

Praised by clients for its ‘endless experience and care‘, the team at Baker McKenzie displays deep bench strength across a wide variety of matters, including pharmacovigilance, product registration, pricing, reimbursement procedures, and the implementation of patient support programmes. Montserrat Llopart leads the team from Barcelona, utilising her longstanding regulatory expertise to advise on compliance audits, the drafting of codes of professional ethics, and clinical trial contracts. In Madrid, ‘excellent‘ practice head Cecilia Pastor acts for healthcare companies in a host of matters, including corporate restructurings and global supply chains, while Ester Navas assists medical device and pharma companies with the regulatory aspects of their promotional activities, price discounting issues, and contractual matters involving third parties.

Cuatrecasas provides support to a diverse client base of biotech corporates, hospitals, and research institutes. Leading the team from Barcelona, Elena Cuatrecasas acts for a multitude of clients within the biotech and pharma sectors in M&A and contractual matters, while Ariadna Casanueva regularly assists with clinical trial, co-promotion, and distribution agreements, as well as pricing and reimbursement matters. Málaga-based Jorge Robles, a key contact for public law issues, is known for his deep knowledge of the regulations governing medical devices and medicinal products.

Kiko Carrión, Marta González, and Alberto Dorrego jointly lead the ‘excellent‘ Madrid-based practice at Eversheds Sutherland, which acts for a variety of biochemical companies and drug manufacturers. Carrión regularly advises on SPC, trade mark, and patent disputes within the pharma and biotech industries, while González has a great deal of expertise in product liability claims and patent infringement actions. With extensive experience in proceedings before the Constitutional Court, Dorrego is noted for his extensive knowledge of public-private partnerships and public contracts. Eduardo Buitrón frequently assists global pharma companies with licensing, supply and e-health tech agreements.

Garrigues‘ ‘extraordinary‘ practice handles a broad range of matters for medical device and healthcare product manufacturers, pharma and biotech companies, and both public and private hospitals. Practice head José Fernández-Rañada is known for his extensive corporate expertise, regularly advising on M&A, spin-offs, and corporate restructurings. Carolina Pina is the main contact for IP-related matters, while Javier Manchado primarily advises public authorities and private companies on public procurement issues, particularly in relation to the award and performance of public sector contracts.

Praised for its ‘phenomenal coordination‘ and ‘excellent‘ experience, the team at Pérez-Llorca regularly assists clients with the assessment of dosing regiment, second medical use, and compound patents, in addition to handling multijurisdictional disputes concerning SPCs. Eduardo Castillo, noted for his vast, longstanding knowledge of IP and unfair competition litigation within the pharma and biotech industries, and Juan Rodríguez Cárcamo jontly head up the Madrid-based team. Rais Amils is an IP litigator in Barcelona with expansive expertise in the intersection between IP right enforcement and antitrust law. Álvaro de Castro maintains an IP and unfair competition-focused practice, regularly acting in cases concerning the infringement and validity of copyrights and patents.

Andersen handles a varied range of mandates, including M&A, the data protection aspects of clinical trials and pharmacovigilance-related matters. The group is also adept at advising on criminal risk management systems and information exchanges. Working out of the Madrid office, Isabel Martínez Moriel has broad knowledge of data protection and privacy issues. Morial assists with numerous international data transfers and privacy shields, and regularly appears before the Spanish Data Protection Agency.

The team at DLA Piper assists a variety of global pharma and technology companies in regulatory mandates involving market access, distribution agreements, and awareness programmes. Practice co-head Paula González De Castejón, a name to note for pharma and medical device clients, excels in market access issues, clinical trial agreements, pricing and reimbursement matters. Diego Ramos combines his knowledge of IP, technology, and data protection to assist clients with outsourcing issues.

DWF-RCD‘s practice exhibits broad expertise in the drafting of agreements concerning the use of genetic material, pharmacovigilance issues, and data protection matters relating to treatments. Noted for his deep knowledge of venture capital-related matters, Ignasi Costas leads the team which is primarily based in Barcelona. Corporate specialist Alejandro Griffiths advises tech companies on research collaboration contracts and internal regulations. Oscar Alegre is well versed in advising biotech companies on technology transfers and R&D issues, while Judith Saladrigas in Madrid regularly assists research centres and universities.

Primarily based in Madrid, the robust team at Gómez-Acebo & Pombo maintains its focus on innovation within the sector, primarily concentrating on R&D and commercialisation issues. Regulatory expert Irene Fernández Puyol leads the team, advising on the full range of issues relating to medicinal products, promotional materials, and medical devices. Jesús Muñoz Delgado has ample expertise in IP and unfair competition mandates, particularly within the biotech space. Dual qualified in California and Spain, Rick Silberstein handles corporate governance mandates from the Barcelona office, while Alex Carbonell is known for his deep knowledge of M&A and tech transactions.

‘Powerhouse‘ IP boutique HOYNG ROKH MONEGIER leverages its European network to assist clients with the full gamut of IP matters. Luis Fernández Novoa leads the team in Madrid, and is noted for his knowledge of IP disputes across the pharma and biotech industries. IP litigation specialist Laura Cantero regularly represents clients in patent, trade mark, and copyright cases, while Álvaro Velázquez frequently appears before commercial and administrative courts in disputes involving advertising and labelling issues.

Ramón y Cajal Abogados‘ Madrid-based team advises clients on the financing of medications, the advertising of medicines, and the direct supply of medication to hospitals. Practice co-head José Ignacio Vega maintains a public law-focused practice, frequently assisting clients with public procurement issues. Co-head Norman Heckh is noted for his knowledge of commercial law, cybersecurity and data protection matters.